Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis—A meta-analysis
- 18 June 2009
- journal article
- research article
- Published by Elsevier
- Vol. 27 (35) , 4747-4753
- https://doi.org/10.1016/j.vaccine.2009.05.084
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- First generation leishmaniasis vaccines: A review of field efficacy trialsVaccine, 2008
- Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica ParasitesPLoS Medicine, 2006
- Drug Resistance in LeishmaniasisClinical Microbiology Reviews, 2006
- Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental modelsZeitschrift Fur Parasitenkunde-Parasitology Research, 2005
- Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasisVaccine, 2004
- Leishmaniasis– current chemotherapy and recent advances in the search for novel drugsTrends in Parasitology, 2003
- Stepwise safety trial of a killed Leishmania vaccine in IranClinics in Dermatology, 1996
- Comparative safety and immunogenicity trial of two killed Leishmania Major vaccines with or without BCG in human volunteersClinics in Dermatology, 1996
- Vaccine for prophylaxis and immunotherapy, BrazilClinics in Dermatology, 1996
- IMMUNOTHERAPY VERSUS CHEMOTHERAPY IN LOCALISED CUTANEOUS LEISHMANIASISPublished by Elsevier ,1987